Showing 2,081–2,100 of 18,047 drug recalls
Drug Recall
Terminated
Historical record Class II
Dicyclomine Hydrochloride Tablets, USP 20 mg, 100 Tablets, Rx only, Manufactured For: Teva Pharmaceuticals USA, Parsippany, NJ 07054. NDC: 0591-0795-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Colgate Total SF Toothpaste, Net Wt 4.8 oz (136 g), Stannous Fluoride 0.454%, Clean Mint, Dist. by: COLGATE-PALMOLIVE CO., New York, NY 10022 USA by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 0378-6232-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
CHLORTHALIDONE Tablets, USP, 25MG, 1000 Tablets, Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854 USA; Manufactured For: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA. NDC: 43598-719-10 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Bumetanide Tablets, USP, 2 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213 India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Low Dose ASPIRIN, 81 mg, 120 Enteric Coated Tablets, Distributed by: Rugby Lavoratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152. NDC: 0536-1234-41 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Doses, Rx only, Manufactured for: Organon LLC, a subsidiary of Organon & Co., Jersey City, NJ 07302; Manufactured by: MSD International GmbH (Singapore Branch) Singapore 638030, Singapore. NDC: 78206-114-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
ARMOUR THYROID (thyroid tablets, USP), 2 GRAIN (120 mg), 100 Tablets, Rx Only, Distributed by: Allergan US, INc., Madison, NJ 07940. NDC: 0456-0461-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Aripiprazole Tablets, USP, 5 mg, 30 Tablets per bottle, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 65162-897-03 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
AMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540. NDC: 0781-5060-20 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
ALLOPURINOL Tablets, USP 300 MG 500 count Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106. NDC: 55111-730-05 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
ALBUTEROL SULFATE IN 90MCG per actuation, 200 Metered Inhalations, Rx Only, 8.5 g Net Contents, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India. NDC: 68180-963-01 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
ALBUTEROL SULFATE HFA Inhalation Aerosol, 90MCG per actuation, 200 Metered Inhalations, Net Wt. 18 g, Rx Only, Manufactured for: Prasco Laboratories, Mason, OH 45040 USA. NDC: 66993-019-68 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class II
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials (2 pouches of 30 - 3 mL vials each), Manufactured By: The Ritedose Corporation, Columbia, SC 29203; Distributed By: Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-840-64 by CARDINAL HEALTHCARE
Reason
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Recall initiated
January 26, 2022 Reported by FDA
January 3, 2024 Distribution
Nationwide USA
View recall →
Drug Recall
Terminated
Historical record Class III
ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10 by GlaxoSmithKline LLC
Reason
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification Recall initiated
December 12, 2023 Reported by FDA
January 3, 2024 Distribution
Distributed Nationwide in the USA and Puerto Rico.
View recall →
Drug Recall
Terminated
Historical record Class I
Odor-Eaters Spray Powder, Tolnaftate 1% Antifungal, packaged in a) 4 oz. aerosol cans (UPC 0 41388 0041 2, NDC 10157-4645-1) and b) 5.3 oz. aerosol cans (UPC 0 41388 00411 2, NDC 10157-4645-2) Blistex P.O. Box 5392, Oak Brook, IL 60522-5392. by Blistex Inc
Reason
Chemical contamination: Presence of benzene Recall initiated
November 17, 2021 Reported by FDA
December 27, 2023 Distribution
Nationwide with the USA, Canada and Korea
View recall →
Drug Recall
Ongoing
Historical record Class I
THE ROCK, Male Sexual Performance Enhancement Capsules, 1200 mg, 1 count blister card, Distributed by Steele Productions: Hallandale, FL 33008 UPC 6 61799 95052 7 by Noah's Wholesale LLC
Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with Sildenafil an ingredient found in an FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug. Recall initiated
October 16, 2023 Reported by FDA
December 27, 2023 Distribution
Florida, Bahamas, Turks & Caicos Islands
View recall →
Drug Recall
Ongoing
Historical record Class II
NYSTATIN 150 MU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-1, Bar code 3 51552 00411 5 by Fagron, Inc
Reason
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect. Recall initiated
December 11, 2023 Reported by FDA
December 27, 2023 Distribution
Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.
View recall →
Drug Recall
Ongoing
Historical record Class II
NYSTATIN 2 BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-4, Bar code 3 51552 00414 6 by Fagron, Inc
Reason
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect. Recall initiated
December 11, 2023 Reported by FDA
December 27, 2023 Distribution
Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.
View recall →
Data last updated: November 1, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
